Can virtual reality from home sharpen social skills in schizophrenia?
NCT ID NCT05017532
First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time
Summary
Researchers are testing whether a virtual-reality program called RC2S+ can be used remotely to help people with schizophrenia improve social cognition, such as recognizing emotions and understanding others' thoughts. The study enrolls 15 adults with schizophrenia or related psychotic disorders who have difficulty in social cognition. Participants use the program at home, and researchers measure how acceptable and feasible it is, along with any early effects on social thinking and symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A personalized cognitive remediation program called RC2S+ that uses virtual reality to simulate daily social interactions, delivered remotely.
- What this could lead to
- If it works, this could offer a convenient, home-based way to help people with schizophrenia improve social skills like reading emotions and understanding others' perspectives.
- What could go wrong
- This is a very small early trial with only 15 participants, so results may not apply broadly. The program may be hard to use remotely, and any benefits might not last.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
15 people
The number who actually took part.
- Started
-
Jan 2022
- Finished
-
Feb 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. DSM-5 diagnosis of schizophrenia or a related psychotic disorder 2. Being followed and treated by a clinician of the Douglas Mental Health University Hospital 3. Being 18 or older 4. Having an objective difficulty in social cognition (i.e. emotion recognition, theory of mind, attributional bias, social perception) defined as a performance equal of below 1 standard deviation from the normative group on one of the following measures: Penn Emotion Recognition Task (ER-40; Emotion recognition), Combined Stories Test (COST; Theory of mind), Social Knowledge test (SKT; Social knowledge) or Interpersonal, Personal and Situational Attributions Questionnaire (IPSAQ; Attributional style). This criterion is mandatory since we need to be able to remediate a difficulty during cognitive remediation. 5. Being considered symptomatically stable and capable of using the online platforms, as judged by their primary clinicians (i.e., psychiatrist, case manager, psychologist) 6. Having access to digital technology, Internet and access to a private space (a room where the participant can be alone) 7. Being able to nominate an emergency contact Exclusion Criteria: 1. Evidence of an organic cause for cognitive difficulties (e.g. neurological disease, history of brain trauma) 2. History of mental retardation or autism spectrum disorder 3. Being hospitalized at the time of recruitment 4. Inability to speak or read French or English
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cognitive impairment are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Douglas Mental Health University Institute
Montreal, Quebec, H4H 1R3, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain zaps may curb antipsychotic weight gain
- Can antipsychotics rewire the Brain's dopamine system? a scan study investigates
- Can a nasal insulin spray rev up brain energy and sharpen thinking in psychosis?
- A blocked neck artery may steal your memory. can a procedure bring it back?
- AI hunts for early clues to Parkinson's and Alzheimer's progression
- Can talk therapy and social coaching ease early psychosis?